News Archive

July 10, 2018 — Researchers discovered an unexpected twist in the battle versus tumors. Tumors employ a protein called PD-L1 to blind T cells from functioning. PD-L1 protects tumors through a “molecular brake” known as PD-1. Researchers have found that some tumor cells display not only their PD-L1 weapon, but also the PD-1 brake, essentially becoming a neutralizing function. The unexpected mechanism could help determine whether a cancer patient will respond to immunotherapy.

July 9, 2018 — Through x-ray crystallography and kinase-inhibitor specificity profiling, University of California San Diego School of Medicine researchers, in collaboration with researchers at Peking University and Zhejiang University, reveal that curcumin, a natural occurring chemical compound found in the spice turmeric, binds to the kinase enzyme dual-specificity tyrosine-regulated kinase 2 (DYRK2) at the atomic level. This previously unreported biochemical interaction of curcumin leads to inhibition of DYRK2 that impairs cell proliferation and reduces cancer burden.

July 9, 2018 — UC San Diego has selected Kit Pogliano, a professor of molecular biology, as its new dean for the Division of Biological Sciences. Pogliano was selected after a national search and will begin her new appointment on Sept. 15, 2018. She is the fourth dean of the division and its first female leader. She will lead a renowned division that consistently ranks among the world’s best in biology research and education.

June 21, 2018 — With microbial resistance to antibiotics growing into a major global health crisis, researchers at University of California San Diego School of Medicine, in collaboration with national research institutions and private industry, are leveraging hard-won expertise to exploit a natural viral enemy of pathogenic bacteria, creating North America’s first Center for Innovative Phage Applications and Therapeutics (IPATH).

June 14, 2018 — The Pew Charitable Trusts has announced that UC San Diego Biological Sciences Assistant Professors Matthew Daugherty and Enfu Hui have been selected to the 2018 class of Pew Scholars in the Biomedical Sciences. Pew also announced that Diego Alvarez and Grisel Cruz Becerra, Biological Sciences postdoctoral researchers, have been named new Pew Latin American Fellows in the Biomedical Sciences.

June 14, 2018 — Graphene electrodes could enable higher quality imaging of brain cell activity thanks to new research by a team of engineers and neuroscientists at the University of California San Diego. The researchers developed a technique, using platinum nanoparticles, to lower the impedance of graphene electrodes by 100 times while keeping them transparent. In tests on transgenic mice, the electrodes were able to record and image neuronal activity (calcium ion spikes) at both the macroscale and single cell levels.

June 13, 2018 — A team led by researchers at UC San Diego’s Department of Chemistry and Biochemistry and SDSC has used machine learning techniques to develop models for simulations of water with “unprecedented accuracy.” Published online in The Journal of Chemical Physics, the research demonstrates how popular ML techniques can be used to construct predictive molecular models based on quantum mechanical reference data.

June 13, 2018 — Neglected tropical diseases are a group of chronic and disabling parasitic infections that primarily affect poor and underserved communities. These diseases affect more than 1 billion people globally, yet are rarely the target of new drug discovery efforts. Leveraging its strengths in molecular biology, clinical research and pharmaceutical sciences, the University of California San Diego has now launched a new Center for Anti-Parasitic Drug Discovery and Development to address this unmet need in global health.

May 16, 2018 — A UC San Diego-led team has identified a gene that helps prevent the harmful buildup of proteins that can lead to neurological disorders such as Alzheimer’s and Parkinson’s disease. As published in Nature, the researchers found that the “Ankrd16” gene acts like a failsafe in proofreading and correcting errors to avoid the abnormal production of improper proteins.

May 14, 2018 — UC San Diego scientists have unraveled a decades-long mystery on how genes are activated. Until activated, human genes are blocked by structures known as nucleosomes, components that serve to package DNA inside cells. Scientists have been trying to determine how these nucleosome roadblocks clear out to allow genes to be turned on. Now, a team of scientists has identified a key factor that partially unravels nucleosomes and clears the way for genes to activate. The identification of “NDF,” or nucleosome destabilizing factor, is described May 14 in the journal Genes & Development. The researchers say the finding provides a new perspective on how genes are turned on and off—knowledge useful in the study of human diseases such as cancer, which can be caused by improper gene activity.